MTOR and tuberous sclerosis: Another mTOR inhibitor, sirolimus, has been evaluated for TSC-associated seizures, with one study showing that early treatment with sirolimus, particularly before 6 months of age, delayed seizure onset and the development of infantile spasms [98].